Selecta Biosciences (SELB) to Merge with Cartesian Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
13.11.2023 - – Merger creates a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease – – Cartesian’s wholly owned pipeline includes a Phase 2 lead asset, Descartes-08, for which deep and durable responses . Seite 1
Selecta Biosciences, Inc. (SELB) announced Monday that it has merged with biotechnology company Cartesian Therapeutics, Inc. In connection with the merger, Selecta announced a $60.
/PRNewswire/ A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled.